Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Transmembrane protein 225B (TMEM225B)** is a poorly characterized multi-pass transmembrane protein. Closely related animal orthologs, such as rat TMEM225, are expressed specifically in the testis and are associated primarily with germ cell lineages, showing increased expression during adult spermatogenic stages[1][2]. The rat and mouse orthologs are composed of four predicted transmembrane domains and localize mainly to regions near the nuclear envelope and acrosomal membranes rather than the cell surface[1][2]. In mice, TMEM225 has been shown to interact with protein phosphatase 1γ2 (PP1γ2) and to potentially modulate its activity through a conserved RVxF motif, suggesting a possible regulatory role in sperm maturation and function[2]. There is no evidence directly characterizing human TMEM225B's physiological or pathological roles, nor is it recognized as a therapeutic drug target or established biomarker in current biomedical literature[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 225B (TMEM225B).